i would have thought the vast majority of patients in this
i would have thought the vast majority of patients in this long trial were finished prior to Nov. By Dec I thought just a mere handful of patients were still waiting for their final 4 week post treatment visit. That means data on all but a few should have been getting wrapped up long before the trial officially ended in late Dec. CRO should have been checking in on the sites to establish how far along they were as many must have had only a handful of patients since we had 33 sites or so.
If we are to say this time is nothing out of the ordinary to merely collect the final data and tabulate it (unless they have but one adding machine) then the analyzing could take months. I heard nothing from the many solid medical types on any board say that we were looking at 6 months or so to get top line results back in late 2017. If that was expected, mgt sure could have helped out by providing some rough guidelines as to timing.
The only strong caution I heard was from you that the analyzing of the data could take quite some time to make sure no mistakes are made. I can accept that, the tabulation end though seems way overdue.
But then I have no clinical trials experience so I just add it up as another learning point.
I know there must have been a lot of buying in Feb and Mar by those unaware of the time delay so many are left in the red since buying could have been delayed another month or two since results are still not on the real near horizon (as in 6 weeks or less) IMO.
Not really ticked off, just venting how continually I (and likely others) have misplayed the time line necessary to buy at the right time.
No more negative posts forthcoming from me.
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...
Continue Reading
Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...
Continue Reading
Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...
Continue Reading
A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...
Continue Reading
Cooper Standard's Balancing Act Alright, let’s cut straight to the chase. Cooper Standard (NYSE: CPS) finds itself dabbling in a tricky dance—juggling sparkling new business awards while grappling with stubborn inflationary headwinds and a kick to the shin from production volume shortfalls. Third quarter of 2026, and they reported net new business awards worth a hefty...
Continue Reading
Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...
Continue Reading
Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...
Continue Reading
Cogent Communications' Latest Quarter Insights When you hitch your wagon to the communications and internet industry, there's no escaping the hard truths from meticulous quarterly reports. Take Cogent Communications' latest Q3 2026 results, where numbers speak louder than words. Service revenue dipped to $231.2 million for the quarter, a 1.8% drop compared to Q2. And...
Continue Reading
Fosun's Nine-Year CIIE Journey Fosun's been trotting out its innovations at the China International Import Expo (CIIE) for nine straight years. With 162 countries in the mix this time around, they're not just playing house—it’s downright world-class boasting. Fosun’s rolling out their hard-hitters in the medical tech space, showing they’re no rookies to the...
Continue Reading
Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...
Continue Reading
Top 5 Most Recently Viewed Articles
Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...
Continue Reading
LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...
Continue Reading
Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...
Continue Reading
The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...
Continue Reading
Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....
Continue Reading